---
layout: post
title: "赛诺菲(SNY.US)和黑石(BX.US)合作开发多发性骨髓瘤疗法"
date: 2022-03-15 15:42:53 +0800
categories: zhitongcaijingwang
tags: 智通财经网新闻
---
<p style="display:none;height:1px;overflow:hidden;"><br /></p><!-- EM_StockImg_Start --><p style="text-align:center;"><a href="http://quote.eastmoney.com/unify/r/105.SNY" data-code="SNY|105|7" data-code2="SNY|105|3|" class="EmImageRemark" target="_blank"><img src="https://webquoteklinepic.eastmoney.com/GetPic.aspx?nid=105.SNY&imageType=k&token=28dfeb41d35cc81d84b4664d7c23c49f&at=1" border="0" alt="K图 SNY_0" data-code="K SNY|105|7" data-code2="K SNY|105|3|" style="border:#d1d1d1 1px solid;" width="578" height="276" /></a></p><!-- EM_StockImg_End --><p style="display:none;height:1px;overflow:hidden;"> </p><!-- EM_StockImg_Start --><p style="text-align:center;"><a href="http://quote.eastmoney.com/unify/r/106.BX" data-code="BX|106|7" data-code2="BX|106|1|" class="EmImageRemark" target="_blank"><img src="https://webquoteklinepic.eastmoney.com/GetPic.aspx?nid=106.BX&imageType=k&token=28dfeb41d35cc81d84b4664d7c23c49f&at=1" border="0" alt="K图 BX_0]" data-code="K BX|106|7" data-code2="K BX|106|1|" style="border:#d1d1d1 1px solid;" width="578" height="276" /></a></p><!-- EM_StockImg_End --><p>赛诺菲(SNY.US)和黑石(BX.US)日前宣布，双方将开展一项风险分担合作，根据合作协议，黑石旗下Blackstone Life Sciences将提供高达3亿欧元的资金，以加速用于治疗多发性骨髓瘤患者的CD38抗体Sarclisa的研究和临床开发项目。如果项目成功，Blackstone Life Sciences将有资格从该疗法的皮下制剂未来销售中获得提成费。<br /></p><p>Sarclisa皮下制剂的临床试验将于下半年开始。Sarclisa已经获得监管部门的批准，用于静脉注射治疗某些多发性骨髓瘤患者。</p><p class="em_media">（文章来源：智通财经网）</p>

<http://finews.zning.xyz/html_News/NewsShare.html?infoCode=NW202203152310179112>

[返回智通财经网新闻](//finews.withounder.com/category/zhitongcaijingwang.html)｜[返回首页](//finews.withounder.com/)